Quantitative Analyses of Normal Tissue Effects in the Clinic (QUANTEC): an introduction to the scientific issues.
about
Genetics and genomics of radiotherapy toxicity: towards predictionCellular Pathways in Response to Ionizing Radiation and Their Targetability for Tumor RadiosensitizationRadiation survivors: understanding and exploiting the phenotype following fractionated radiation therapyA critical review of recent developments in radiotherapy for non-small cell lung cancerData-Based Radiation Oncology: Design of Clinical Trials in the Toxicity Biomarkers Era.Radiotherapy for benign disease; assessing the risk of radiation-induced cancer following exposure to intermediate dose radiation.A dose-volume histogram based decision-support system for dosimetric comparison of radiotherapy treatment plans.Normal tissue complication probability modeling for cochlea constraints to avoid causing tinnitus after head-and-neck intensity-modulated radiation therapy.Strategic evaluation of interventions to prevent consequential late proctitis after prostate radiation therapy: new clinical trial designs should be considered.Dose-volume parameters predict for the development of chest wall pain after stereotactic body radiation for lung cancer.Adjuvant concurrent chemoradiation using intensity-modulated radiotherapy and simultaneous integrated boost for resected high-risk adenocarcinoma of the distal esophagus and gastro-esophageal junctionData-driven Markov models and their application in the evaluation of adverse events in radiotherapy.No increase in toxicity of pelvic irradiation when intensity modulation is employed: clinical and dosimetric data of 208 patients treated with post-prostatectomy radiotherapyFunctional Data Analysis Applied to Modeling of Severe Acute Mucositis and Dysphagia Resulting From Head and Neck Radiation Therapy.Visualization of a variety of possible dosimetric outcomes in radiation therapy using dose-volume histogram bandsDosimetry for radiopharmaceutical therapyStrategies to tackle the challenges of external beam radiotherapy for liver tumorsA Novel Methodology using CT Imaging Biomarkers to Quantify Radiation Sensitivity in the Esophagus with Application to Clinical Trials.Normal tissue studies in radiation oncology: A systematic review of highly cited articles and citation patterns.Adjuvant chemotherapy and acute toxicity in hypofractionated radiotherapy for early breast cancerImpact of late toxicities on quality of life for survivors of nasopharyngeal carcinomaOutcomes after intensity-modulated versus conformal radiotherapy in older men with nonmetastatic prostate cancer.The current progress and future prospects of personalized radiogenomic cancer study.Identification of SNPs associated with susceptibility for development of adverse reactions to radiotherapyLate symptoms in long-term gynaecological cancer survivors after radiation therapy: a population-based cohort study.Assessment of transposed ovarian movement: how much of a safety margin should be added during pelvic radiotherapy?Analytical model for out-of-field dose in photon craniospinal irradiationPredicting outcomes in radiation oncology--multifactorial decision support systemsThe Prediction of Radiotherapy Toxicity Using Single Nucleotide Polymorphism-Based Models: A Step Toward Prevention.Comparison of hybrid volumetric modulated arc therapy (VMAT) technique and double arc VMAT technique in the treatment of prostate cancer.Long-term outcome and toxicity of hypofractionated stereotactic body radiotherapy as a boost treatment for head and neck cancer: the importance of boost volume assessment.MIRD pamphlet No. 23: quantitative SPECT for patient-specific 3-dimensional dosimetry in internal radionuclide therapyCorrelation of conventional and conformal plan parameters for predicting radiation pneumonitis in patients treated with breast cancer.Dosimetric and radiobiological comparison of helical tomotherapy, forward-planned intensity-modulated radiotherapy and two-phase conformal plans for radical radiotherapy treatment of head and neck squamous cell carcinomas.Radiobiological model-based bio-anatomical quality assurance in intensity-modulated radiation therapy for prostate cancer.The clinical case for proton beam therapy.Stereotactic body radiation therapy in the re-irradiation situation--a review.STROGAR - STrengthening the Reporting Of Genetic Association studies in Radiogenomics.Personalized treatment planning with a model of radiation therapy outcomes for use in multiobjective optimization of IMRT plans for prostate cancerPatient-reported genitourinary toxicity for long-term prostate cancer survivors treated with radiation therapy
P2860
Q21183971-42FFFE9F-2249-490F-8B2A-994997886977Q26771165-3F51FC30-3BE9-482B-8E6E-DE9461C8D943Q27026696-D8BEA90F-E90F-4C32-9EF4-FF1E0DFEE41DQ28079625-50E0BDED-5FC7-4FC2-838A-75A283FA148EQ30234489-B046F0E0-7D1D-4720-964A-D0540C0D69B4Q30368547-27164009-6135-4D00-829F-F5BCFE3A71C0Q30395188-61E1D06A-3FDC-4ADF-8D90-AD62E07C3CEFQ30402671-701A0ADE-CF6F-456D-9C21-817CE748CF2BQ30406008-BC654B51-C7EF-41BD-B49F-1C18DC279000Q30421587-EBB54806-72B6-4C01-8642-3F262E685E5BQ30537735-FEE9FB47-D3DC-41C5-87A5-326FE91CEE61Q30653195-7DF6DF00-CC98-485B-A5C0-9817BDA62403Q31083823-6291FF83-C39B-45D0-A2BD-2828F2A00BAEQ31139488-3B56C4AF-E226-46E5-968C-489AAF24AF62Q33274509-9D0F9D14-5C94-4DCD-A870-B04EB6C23EC1Q33665116-7165F568-3382-4934-8421-C5C5D0387562Q33706721-E72BC0DA-690F-404A-A155-D20C35AD4EE9Q33920822-E9E6D977-AD72-4476-B8B2-D67177119441Q33967649-D6EAD4A3-E1C8-4FE6-9A19-684F92C32C12Q34520010-54FF49A6-C30F-45E4-92E9-AC2D56CF4B32Q34587507-B2DFDFE1-2952-46E8-BD35-402E4164823DQ34696349-5C8F1181-2328-4CD1-9D78-E49F55DB4DCFQ35083627-4CC82947-0A6E-43F9-9ADC-42455C0C57E2Q35084218-07E3252E-C3A5-4100-9D5E-6257CD1EC68BQ35208192-7A026313-71AF-4205-B694-A579A28B1321Q35234059-80024065-FFD7-490A-A064-5CF22675DB5CQ35398974-C7AEC677-1F82-4DFE-B827-9E41CAD9BDDCQ36014711-C9322831-B0AA-4826-A3EB-75A2498ACA02Q36077772-6E167415-5783-4B1C-AB00-997295E1683EQ36079275-C1180F6A-C605-4C4A-A7C0-01CC17172180Q36143371-A3124C5C-DBDD-4835-9BF9-E9D9ED720199Q36302205-C5D89AF0-5D8A-4E9F-A92D-CFE44BEC4ADBQ36310203-FF743233-00BA-4A1A-9D88-B4E941702B27Q36325173-3D17E0B7-498C-4A20-9911-883DD09609F7Q36355783-B76CF29E-0E9B-4AEA-ABB0-B1562E2A0B17Q36547835-27696A50-7769-407C-A2D1-1D434AD6FB5EQ36555837-E2C88A62-C120-4F17-B475-5F6AEB9B3769Q36672778-4C695A1C-EF70-4A04-9B65-FFA50BF8D3F8Q36679026-680ACA6B-7A00-4D91-B2AE-9108102A2041Q36896182-05E1E684-F682-490D-83D6-D6549CBDEF6D
P2860
Quantitative Analyses of Normal Tissue Effects in the Clinic (QUANTEC): an introduction to the scientific issues.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Quantitative Analyses of Norma ...... tion to the scientific issues.
@ast
Quantitative Analyses of Norma ...... tion to the scientific issues.
@en
type
label
Quantitative Analyses of Norma ...... tion to the scientific issues.
@ast
Quantitative Analyses of Norma ...... tion to the scientific issues.
@en
prefLabel
Quantitative Analyses of Norma ...... tion to the scientific issues.
@ast
Quantitative Analyses of Norma ...... tion to the scientific issues.
@en
P2093
P2860
P50
P1476
Quantitative Analyses of Norma ...... tion to the scientific issues.
@en
P2093
Andrew Jackson
Avi Eisbruch
Ellen D Yorke
Lawrence B Marks
Louis S Constine
P2860
P356
10.1016/J.IJROBP.2009.09.040
P407
P433
P577
2010-03-01T00:00:00Z